Jerry Baty

Chief Financial Officer at Chrysalis BioTherapeutics

Is a Partner with Newport LLC, providing C-level advisory services to middle-market companies in the areas of event/transaction readiness, management and other transformational events either through a pure advisory role or as an interim or fractional executive; CEO of Brazos BioMedical, LLC; CEO of StitchLock, Inc and Founder/CFO of Emerald Mobility. Mr. Baty also serves as Chairman of the Board for Seraxis Holdings; member of the Houston Symphony Audit Committee; member of the Lighthouse for Students Board of Directors; and was a member of the Shelbie.org Board of Directors. Prior to this, Mr. Baty was the CEO of SafeTech USA, Inc., a nation-wide company in the aviation safety equipment industry, which he sold to a Private Equity backed European group of similar companies. Following the sale, he ran the consolidate U.S. operation for two years. Mr. Baty was also CFO for several development-stage companies in the pharmaceutical, biotechnology and medical device industries. Mr. Baty holds a J.D. from South Texas College of Law, an M.B.A. from the University of Houston, C.T. Bauer College of Business, and a B.B.A. in Accounting from Stephen F. Austin State University. He is a licensed CPA in Texas and is licensed to practice law in New York.


Org chart

Sign up to view 1 direct report

Get started